Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nucific vs OnlyRx

Nucific
Graded #417

Lower grade

vs+4.699999999999996
OnlyRx
Graded #311

Higher grade

The verdict

OnlyRx takes it — 60.9/100 to 56.2/100.

OnlyRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OnlyRx is a cash-pay GLP-1 telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral disintegrating tablet (ODT) forms — an uncommon needle-free option.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNucific +3
45
42
Dose & formulationOnlyRx +35
53
88
Clinical oversightNucific +4
76
72
Labs & monitoringEven
52
52
FulfillmentNucific +15
67
52
Contract termsOnlyRx +14
41
55
Nucific · left barOnlyRx · right bar

The numbers

MetricNucificOnlyRx
WeighScore56.2/10060.9/100
GradeCC
Scorecard rank#417#311
SemaglutideNot disclosed$179/mo (starting dose, promotional rate, compounded)
TirzepatideNot disclosed$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Nucific

Graded #417 · C

Strengths

  • Founder is named and credentialed: Dr. Amy Lee, MD, triple board-certified in Internal Medicine, Obesity Medicine and Clinical Nutrition
  • Cites SURMOUNT-1 properly, naming the trial, the 20.9% average and the Jastreboff NEJM 2022 source
  • Discloses that featured patients were compensated for their time
  • Labels its NAD+ decline chart as illustrative and not a measurement, with an unusually careful methodology note
  • Offers compounded, microdosed and brand-name Ozempic and Zepbound in one catalogue

Where it loses points

  • No price is published anywhere; every option is gated behind a three-minute quiz
  • The LegitScript badge is a self-hosted image with generic alt text rather than the issued embed, so the certification could not be verified
  • A BBB Accredited A+ claim is displayed without a link to the BBB profile
  • No state list and no named pharmacy, only licensed U.S. pharmacies
  • Before-and-after photographs are used alongside compensated testimonials
OnlyRx

Graded #311 · C

Strengths

  • Four-pharmacy network: Belmar, Strive, Epiq Scripts, and Casa Pharma RX
  • Named prescribers on the public site: Dr. Carr (MD), Dr. Tenbrink (MD), Dr. Italia (MD), Dr. Mansour (DO)
  • Oral disintegrating tablet (ODT) form for both semaglutide and tirzepatide — good for needle-averse patients
  • Pricing, drug list, pharmacy partners, and physician roster all visible on the public site
  • LegitScript Certified

Where it loses points

  • Promo pricing ($179 semaglutide injection) is prominent, but post-promo maintenance pricing isn't shown
  • No titration-ladder pricing — you can't see costs at 1.0 mg or 2.4 mg maintenance
  • Refund / cancellation policy not stated on the homepage
  • Lab-work requirement not stated
  • Operating corporate entity not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard